Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Rovi Is Weeks From Long-Acting Risperidone Filing
Long-Acting Letrozole Injectable At Phase I Stage
Nov 26 2019
•
By
Aidan Fry
By the end of this year, Rovi expects to have filed in Europe for long-acting risperidone • Source: Shutterstock
More from Value Added Medicines
More from Products